» Articles » PMID: 25417236

Adolescent and Young Adult Cancer Survival

Overview
Specialty Oncology
Date 2014 Nov 24
PMID 25417236
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Adolescent and young adults (AYAs) face challenges in having their cancers recognized, diagnosed, treated, and monitored. Monitoring AYA cancer survival is of interest because of the lack of improvement in outcome previously documented for these patients as compared with younger and older patient outcomes. AYA patients 15-39 years old, diagnosed during 2000-2008 with malignant cancers were selected from the SEER 17 registries data. Selected cancers were analyzed for incidence and five-year relative survival by histology, stage, and receptor subtypes. Hazard ratios were estimated for cancer death risk among younger and older ages relative to the AYA group. AYA survival was worse for female breast cancer (regardless of estrogen receptor status), acute lymphoid leukemia (ALL), and acute myeloid leukemia (AML). AYA survival for AML was lowest for a subtype associated with a mutation of the nucleophosmin 1 gene (NPM1). AYA survival for breast cancer and leukemia remain poor as compared with younger and older survivors. Research is needed to address disparities and improve survival in this age group.

Citing Articles

The risk of peripartum cardiomyopathy among pediatric, adolescent, and young adult cancer patients exposed to doxorubicin: an opinion article.

Carfagnini C, Bechara S, Kandula M Front Oncol. 2024; 14:1395465.

PMID: 39600649 PMC: 11588631. DOI: 10.3389/fonc.2024.1395465.


INteractive survivorship program to improve health care REsources [INSPIRE]: A study protocol testing a digital intervention with stepped care telehealth to improve outcomes for adolescent and young adult survivors.

Yi J, Ballard S, Walsh C, Friedman D, Ganz P, Jacobs L Contemp Clin Trials. 2024; 148():107745.

PMID: 39561920 PMC: 11700757. DOI: 10.1016/j.cct.2024.107745.


Global cancer statistics for adolescents and young adults: population based study.

Li W, Liang H, Wang W, Liu J, Liu X, Lao S J Hematol Oncol. 2024; 17(1):99.

PMID: 39434099 PMC: 11492650. DOI: 10.1186/s13045-024-01623-9.


Piloting a Patient-Driven Online Survey to Better Understand Cancer in Adolescents and Young Adults (AYA) in the United States.

Beaupin L, Borinstein S, Yeager N, Rokitka D, Schweitzer J, Uwazurike O Cureus. 2024; 16(7):e63749.

PMID: 39099926 PMC: 11296325. DOI: 10.7759/cureus.63749.


CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.

Price M, Neff C, Nagarajan N, Kruchko C, Waite K, Cioffi G Neuro Oncol. 2024; 26(Supplement_3):iii1-iii53.

PMID: 38709657 PMC: 11073545. DOI: 10.1093/neuonc/noae047.


References
1.
Harrison C, Martineau M . The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol. 2001; 113(1):3-10. DOI: 10.1046/j.1365-2141.2001.02643.x. View

2.
Harlan L, Lynch C, Keegan T, Hamilton A, Wu X, Kato I . Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv. 2011; 5(3):305-14. PMC: 3159756. DOI: 10.1007/s11764-011-0173-y. View

3.
Majhail N, Brazauskas R, Hassebroek A, Bredeson C, Hahn T, Hale G . Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant. 2011; 18(6):861-73. PMC: 3288160. DOI: 10.1016/j.bbmt.2011.10.031. View

4.
Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1):11-30. DOI: 10.3322/caac.21166. View

5.
Johnson R, Chien F, Bleyer A . Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA. 2013; 309(8):800-5. DOI: 10.1001/jama.2013.776. View